BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 29300686)

  • 1. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
    Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
    Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus.
    Liu L; Li Z; Zhou J; Lu J; Li X; Liu J; Xiao N; Wang D
    Virus Genes; 2021 Apr; 57(2):164-171. PubMed ID: 33606171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
    Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
    Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
    J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
    Ning T; Nie J; Huang W; Li C; Li X; Liu Q; Zhao H; Wang Y
    J Infect Dis; 2019 Jan; 219(1):19-25. PubMed ID: 29982588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
    Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
    Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic characteristics of hemagglutinin and neuraminidase of avian influenza A (H7N9) virus in Guizhou province, 2014-2017].
    Wan YH; Zhuang L; Zheng QN; Ren LJ; Fu L; Jiang WJ; Tang GP; Zhang DZ; Li SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1465-1471. PubMed ID: 30462955
    [No Abstract]   [Full Text] [Related]  

  • 10. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
    Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.
    Yang L; Zhu W; Li X; Chen M; Wu J; Yu P; Qi S; Huang Y; Shi W; Dong J; Zhao X; Huang W; Li Z; Zeng X; Bo H; Chen T; Chen W; Liu J; Zhang Y; Liang Z; Shi W; Shu Y; Wang D
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Barman S; Krylov PS; Turner JC; Franks J; Webster RG; Husain M; Webby RJ
    Vaccine; 2017 Mar; 35(10):1424-1430. PubMed ID: 28162820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.
    Sun X; Belser JA; Pappas C; Pulit-Penaloza JA; Brock N; Zeng H; Creager HM; Le S; Wilson M; Lewis A; Stark TJ; Shieh WJ; Barnes J; Tumpey TM; Maines TR
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity.
    Chang P; Sealy JE; Sadeyen JR; Iqbal M
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30282714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor.
    Qi W; Jia W; Liu D; Li J; Bi Y; Xie S; Li B; Hu T; Du Y; Xing L; Zhang J; Zhang F; Wei X; Eden JS; Li H; Tian H; Li W; Su G; Lao G; Xu C; Xu B; Liu W; Zhang G; Ren T; Holmes EC; Cui J; Shi W; Gao GF; Liao M
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29070694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
    Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.